Licensing medicines

This could mean using the medicine for a different condition or a different group of patients, or it could mean a change in the dose or that the medicine is taken in a different way. There is more information about licensing medicines on NHS Choices. Advice Information for the public About this information Licensing medicines What is polycystic ovary syndrome? About metformin Summary of possible benefits and harms Prescribing metformin More information. Prioritised medicines may include those already in the market as well as investigational candidates.

The Prioritisation Report includes one HIV and one TB compounds that could improve standard of care for people living in low- and middle-income countries. For the first time, the report also includes a list of prioritised long-acting technologies and formulations for in-licensing.

Prioritised long-acting technologies and formulations for in-licensing. Access the Prioritisation Report. Access previous reports archives. Further information on wholesale dealer's licences.

Brokering is focused purely on negotiation for buying and selling product. The broker acts as an intermediary for another party in the supply chain, and does not pay for, own or physically handle the product. Wholesale dealing and brokering are different activities, and so companies which perform both activities are required to hold two separate licences.

Following successful registration, the MHRA will enter the broker's registration on a publically accessible UK register, which will enable the broker to broker across the EEA.

Registered brokers are required to notify the MHRA by submitting a variation if the details of their original registration change. In some cases, the MHRA will carry out an inspection following submission of a variation. In addition, registered brokers must submit an annual compliance report to declare compliance with the requirements of the registration and provide details of the systems in place. Further information on broker licences.

If you have any questions on this article or would like to propose a subject to be addressed by Synapse please contact us. Regulatory compliance.